Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results
13/02/2026 13:48
Feb 13 (Reuters) - Medicenna Therapeutics Corp MDNA.TO: MEDICENNA THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE Source text: ID:nGNX3vs62m Further company coverage: MDNA.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results